Plasma derived therapies are unique biologic medicines that are not only life-saving but also life-changing as they make a difference in the standard of life.  They are used in critical care conditions, haemophilia, primary immunodeficiencies, organ transplants, shocks, burns, trauma, several neuro and gynaecological problems as well as rare genetic disorders.

The Plasma Fractionation Unit of Intas Pharmaceuticals is a pioneer in manufacturing plasma derived therapeutics. It strives at making plasma derived therapy affordable and accessible to patients in India.

Located on the industrial belt of Ahmedabad (Matoda), the Plasma Fractionation Unit houses a full-fledged Research & Development unit and a state of art WHO certified manufacturing facility complemented with a GLP compliant Quality control laboratory.  Its strong quality backbone ensures product safety, efficacy & reliability.

The product portfolio of Plasma Fractionation Unit of Intas Pharmaceuticals includes Normal Human Albumin 20% & 25%, Low salt Albumin, Intravenous Immunoglobulin (5% and 10%), Factor VIII, Factor IX and Prothrombin complex. Its aggressive product pipeline is slated for launch in the coming months and set to transform its vision of ‘Plasma Therapy for Life’ into reality!

Join the Intas Plasma Fractionation team to be a part of this journey and make a difference in the lives of millions of people.

Manufacturing authorization by National and International regulatory bodies:

  • MFDS Korea

Types of Products Manufactured

  • Injectable Products
  • Biological Products